Petosemtamab (Synonyms: MCLA 158) |
| Catalog No.GC69690 |
Petosemtamab (MCLA 158)는 EGFR(Kd: 0.22 nM)와 LGR5(Kd: 0.86 nM)에 대한 항체로서, 단일 클론 항체(mAb)입니다. Petosemtamab는 LGR5+ 암 세포에서의 EGFR 신호전달 차단과 수용체 분해를 유발합니다. Petosemtamab는 두경부 편평상피암(HNSCC), 전이성 대장암(CRC) 등의 고형종양 연구에 사용됩니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2213450-26-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Petosemtamab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Petosemtamab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *